Baominh Securities JSC (coded BMS on UPCoM) announces the trading of shares related to an insider of Binh Dinh Pharmaceutical – Medical Equipment JSC (coded DBD on HoSE).
Accordingly, Baominh Securities registered to buy 3 million DBD shares from September 12 to October 11, 2024, to restructure its investment portfolio.
Currently, BMS does not hold any DBD shares. If the transaction is successful, the securities company will own 3.21% of Binh Dinh Pharmaceutical’s capital.
In relation to this, BMS is an organization related to Mr. Phan Tan Thu, a member of Bidiphar’s Board of Directors.
In the market, DBD shares have been range-bound recently. At the close of the session on September 10, the DBD share price stood at VND 40,800 per share. Based on this price, BMS would have to spend approximately VND 122 billion to increase its ownership in DBD.
Earlier, on August 9, KWE BETEILIGUNGEN AG (Switzerland) purchased 87,000 DBD shares, increasing its holding from 7,481,250 shares, or 7.99%, to 7,568,250 shares, or 8.09% of DBD’s capital.
Similarly, from July 8 to August 1, Lighthouse Bond Investment Fund, an organization related to Mr. Phan Tan Thu, a member of the Board of Directors and Chairman of the Fund’s Representative Board, successfully purchased 80,000 DBD shares, increasing its holding to 250,780 shares, or 0.268%.
According to the reviewed semi-annual financial report for 2024, DBD recorded net revenue of nearly VND 817 billion, up 3% over the same period last year (VND 796 billion). Post-tax profit reached approximately VND 140 billion, a slight decrease of 2% (VND 143 billion) compared to the previous year.
For 2024, the company’s shareholders approved a plan to achieve revenue of VND 2,000 billion, up 15% compared to the previous year, and a pre-tax profit of VND 320 billion, unchanged from 2023. The dividend payout ratio was set at 20%, payable in cash or shares.
Thus, compared to the plan approved by the 2024 Annual General Meeting of Shareholders, DBD has achieved 41% of its revenue target and nearly 52% of its profit target for the year.
Regarding investment plans for 2024, Bidiphar expects to disburse more than VND 842 billion. This includes nearly VND 108 billion for the purchase, upgrade, and repair of equipment for its factory at 498 Nguyen Thai Hoc; and over VND 734 billion for ongoing projects: the Oncology Hospital in Nhon Hoi (VND 84 billion), the Aseptic Small Volume Production Plant (nearly VND 624 billion), and the Bidiphar Office Building (VND 16.4 billion), among others.
For new investment projects, Bidiphar has a new investment item for the OSD – Non Betalactam Plant, with a total investment capital of VND 870 billion, dedicated to the production line of solid dosage forms. The plant, constructed in the Nhon Hoi Economic Zone (Quy Nhon city, Binh Dinh province), meets GMP-EU standards and has a capacity of 1.3 billion products/year (equivalent to 100 tons/year). The project is valid until November 21, 2066.
Major Banks Donate Tens of Billions to Support Fellow Citizens in Storm and Flood-Affected Areas
With the above donations, banks, both private and national, aim to contribute additional resources to provide further support to the flood-affected communities.
Why is the disbursement of the VND120 trillion package for social housing construction still slow?
The Ministry of Construction has reported to the Prime Minister on the progress of the proposal to develop and invest in the construction of at least one million social housing units during the period of 2021 to 2030.
